Summary
Bonnie A. Charpentier is an American chemist. In 2019, she served as the president of the American Chemical Society (ACS) and is a past chair of its board of directors.[1][2] She is also the Senior Vice President of Regulatory Affairs and Compliance at Cytokinetics.[3]
Bonnie A. Charpentier | |
|---|---|
| Alma mater | University of Houston, BA (1974) University of Houston, PhD (1981) |
| Awards | Elected American Chemical Society Fellow |
| Scientific career | |
| Fields | Cytokinetics |
Education edit
Bonnie Charpentier completed a bachelor's degree in anthropology in 1974 and a Ph.D. in plant physiology in 1981, both at the University of Houston.[1][4] Her early interest in herbal folk medicines first drew her into anthropology and plant science, then into analytical chemistry and her career overseeing regulatory affairs, quality, and drug safety at pharmaceutical companies.[1]
Career edit
Bonnie Charpentier joined the biopharmaceutical firm Cytokinetics as their Senior Vice President of Regulatory Affairs and Compliance in 2014. Before that, she was Vice President of Regulatory Affairs and Quality at Metabolex (now CymaBay Therapeutics[5]).[6] She also previously held various roles at Genitope Corp, Roche Global Development (a division of Hoffmann-La Roche), Syntex Corporation, and Procter & Gamble where she started her career as an analytical chemist.[3]
From 2019 to 2020, Charpentier served as the president of the American Chemical Society (ACS). Her priorities as ACS president included strengthening collaborations with academia, industry, and professional societies; growing science advocacy programs; and improving scientific literacy.[1]
Awards edit
References edit
- ^ a b c d "Bonnie Charpentier on 'the human element'". Chemical & Engineering News. Retrieved 2019-04-10.
- ^ "Song receives George A. Olah Award from the American Chemical Society | Penn State University". www.psu.edu. Retrieved 2022-03-16.
- ^ a b "Bonnie A. Charpentier, Ph.D." Cytokinetics. Retrieved 2019-04-10.
- ^ "Class Notes — University of Houston Magazine". ssl.uh.edu. Retrieved 2019-04-17.
- ^ "Metabolex Undergoes Capital Restructure and Renames as CymaBay Therapeutics". finance.yahoo.com. 10 December 2013. Retrieved 2019-04-17.
- ^ a b "Radding Award To Bonnie Charpentier | Chemical & Engineering News". cen.acs.org. Retrieved 2019-04-17.
- ^ "2015 ACS Fellows". American Chemical Society. Retrieved 2019-04-17.
- ^ "Oakland chemist Bonnie Charpentier receives prestigious award". American Chemical Society. Retrieved 2019-04-17.